Letter

Neuroleptic prescribing in residents of nursing homes

BMJ 1996; 312 doi: 10.1136/bmj.312.7047.1667 (Published 29 June 1996)
Cite this as: BMJ 1996;312:1667.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Geographical differences make extrapolation difficult

  1. A P Passmore,
  2. V L S Crawford,
  3. T R O Beringer,
  4. K J Fullerton,
  5. P M Mccaffrey
  1. Senior lecturer Lecturer Department of Geriatric Medicine, Queen's University of Belfast, Belfast BT9 7BL
  2. Consultant physician Department of Health Care for the Elderly, Royal Victoria Hospital, Belfast BT12 6AB
  3. Consultant physician Department of Health Care for the Elderly, Belfast City Hospital, Belfast BT9 7AB
  4. Consultant physician Geriatric Medical Unit, Lurgan Hospital, Lurgan, County Armagh BT66 8NX

    EDITOR,—Alice McGrath and Graham Jackson report high neuroleptic prescribing (24%) in Glasgow nursing homes1 and say that these drugs were indicated in only 12% of cases.2

    We studied the use of medication in all patients over 65 years in residential (248) and nursing homes (347), elderly care (260) and psychogeriatric units (112), and a random home sample (127) in north and west Belfast.3 The influence of age, sex, mental score, functional ability, and place of residence was analysed by using multiple …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular